Japan To Support Trials Of 50 Drugs For Critical Diseases
This article was originally published in PharmAsia News
Japan's health ministry says it will provide more than $791 million in support for clinical trials by the nation's drug makers to test 50 selected treatments for incurable and critical ailments. The Ministry of Health, Labor and Welfare said it invites various institutions, organizations and patient groups to recommend the treatments to be covered over a three-year period. The ministry said it also would expedite approvals for such drugs by cutting in half the process for reviewing them, now a one-year process. The drugs to be covered would be limited to those already approved in France, Germany, the United Kingdom and the United States. (Click here for more
You may also be interested in...
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
Erectile dysfunction drug sildenafil, plus treatments for skin conditions such as eczema, are among a bounty of Rx-to-OTC switches approved in Switzerland.